Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Olin

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Journal of Drugs in Dermatology : JDD|July 10, 2014
The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trialsAditya K Gupta, Boni E Elewski, Jeffrey L Sugarman, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1996
Clinical evaluation of global change in Alzheimer's disease: identifying consensusJ T Olin, L S Schneider, R S Doody, et al.
Journal of the American Academy of Dermatology|November 27, 2012
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studiesBoni E Elewski, Phoebe Rich, Richard Pollak, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative StudyL S Schneider, J T Olin, R S Doody, et al.
International Psychogeriatrics|April 25, 2007
Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the futureWarachal E Faison, Susan K Schultz, Jeroen Aerssens, et al.
Leukemia|May 5, 2018
First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cellsM Hojjat-Farsangi, A H Daneshmanesh, A S Khan, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 12, 2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodologyL S Schneider, P N Tariot, C G Lyketsos, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 2, 2002
Provisional diagnostic criteria for depression of Alzheimer diseaseJason T Olin, Lon S Schneider, Ira R Katz, et al.
Expert Review of Neurotherapeutics|October 9, 2009
Provisional diagnostic criteria for depression of Alzheimer's disease: description and reviewJason T Olin, Lon S Schneider, Ira R Katz, et al.
Archives of General Psychiatry|July 16, 2003
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late lifeDennis S Charney, Charles F Reynolds, Lydia Lewis, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Journal of Drugs in Dermatology : JDD|July 10, 2014
The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trialsAditya K Gupta, Boni E Elewski, Jeffrey L Sugarman, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1996
Clinical evaluation of global change in Alzheimer's disease: identifying consensusJ T Olin, L S Schneider, R S Doody, et al.
Journal of the American Academy of Dermatology|November 27, 2012
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studiesBoni E Elewski, Phoebe Rich, Richard Pollak, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative StudyL S Schneider, J T Olin, R S Doody, et al.
International Psychogeriatrics|April 25, 2007
Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the futureWarachal E Faison, Susan K Schultz, Jeroen Aerssens, et al.
Leukemia|May 5, 2018
First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cellsM Hojjat-Farsangi, A H Daneshmanesh, A S Khan, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 12, 2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodologyL S Schneider, P N Tariot, C G Lyketsos, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 2, 2002
Provisional diagnostic criteria for depression of Alzheimer diseaseJason T Olin, Lon S Schneider, Ira R Katz, et al.
Expert Review of Neurotherapeutics|October 9, 2009
Provisional diagnostic criteria for depression of Alzheimer's disease: description and reviewJason T Olin, Lon S Schneider, Ira R Katz, et al.
Archives of General Psychiatry|July 16, 2003
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late lifeDennis S Charney, Charles F Reynolds, Lydia Lewis, et al.
Pageof 14